A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

NCT05781750 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

84

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision.

Conditions

Lupus Nephritis

Interventions

DRUG: zetomipzomib
DRUG: placebo

Sponsor

Kezar Life Sciences, Inc.